virus or ovine lentivirus (OLV) pneumonia, is caused by a nononcogenic, exogenous retrovirus of the Lentiviridae subfamily (3) . The disease is characterized by increasing respiratory distress, chronic weight loss and wasting, and the inevitable death of infected sheep (3) . The disease has been recognized in most parts of the sheep-producing world and is endemic in the United States. OPP virus (OPPV) carriers are usually identified by detecting anti-OPPV antibodies in serum by the agar gel immunodiffusion (AGID) test (2) . However, this test employs a viral antigen that is produced in an inefficient and time-consuming tissue culture system. Therefore, the AGID test is expensive and insensitive for routine clinical laboratory use (5, 11) . Previously, a recombinant polypeptide which represented the N-terminal region of the transmembrane envelope glycoprotein (gp4O) and which appeared to be a major serological marker for OPP was found (6, 7) . These results have permitted the use of a single recombinant gp4O antigen to develop a specific enzyme-linked immunosorbent assay (ELISA) for the detection of OPPV infection in sheep (8) . Synthetic peptides corresponding to the antigenic domains of human immunodeficiency virus gp4l have been incorporated in a clinical diagnostic reagent (1, 13) . Therefore, three oligopeptides representing regions encoded by the portion of the gp4O gene corresponding to the N terminus were synthesized and tested in an assay designed to screen sheep sera for the presence of the OPPV antibody.
OLV peptide sequences were obtained from computer translations by the IBI Pustell sequence analysis program of OLV DNA sequences available through GenBank. The focus of the peptide analysis was on the N-terminal segment of the OPPV gp4O, which covered amino acids 637 to 731 of the gp135 precursor envelope glycoprotein, situated immediately before the gp4O transmembrane segment. This region was analyzed by calculating the antigenic index, hydrophilicity, flexibility, surface probability, and secondary structure (4, 9) . From these analyses, three antigenic sites likely to possess immunodominant epitopes were identified (Fig. 1) . These sites corresponded to amino acid residues 648 to 664, 667 to 683, and 703 to 719, designated TGp-X, TGp-Y, and TGp-Z, respectively ( acids long, were prepared by F-moc solid-phase synthesis (10, 14) . Synthetic peptides were dissolved individually in 0.01 M NaHCO3 buffer (pH 9.6) and were used to coat 96-well microtiter plates (9 p.g per well). The peptides were dried by evaporation overnight at 37°C. Each peptide was tested for reactivity against a panel of sheep sera.
A total of 170 sheep serum specimens were included in this study. Of these specimens, 100 were from known OPP-positive individuals, confirmed by AGID test and recombinant gp40 Western blot (immunoblot) assay. Twenty-two specimens were from the experimental OPP-negative flock of the National Animal Disease Center (Agricultural Research Service, U.S. Department of Agriculture, Ames, Iowa), and these sheep serum specimens were employed as negative controls. Fortyeight samples were collected from a flock that had previously been diagnosed with OPP. These 48 serum specimens were used to compare the sensitivities and specificities of the oligopeptide ELISA and the AGID test.
The specificity of each oligopeptide ELISA was evaluated by using the 100 known seropositive and 22 known seronegative sheep serum specimens. None of the 22 OPP confirmed negative samples showed a false-positive reaction with any of the three oligopeptides. However, the TGp-X, TGp-Y, and TGp-Z peptides were recognized by 84 To compare the sensitivities of the peptide ELISA and the AGID test, we analyzed another 48 sheep serum samples by both methods. Among these 48, the AGID test detected 9 and the TGp-X, TGp-Y, and TGp-Z peptide ELISAs detected 13, 19, and 14 seropositive samples, respectively. Peptides TGp-Y and TGp-Z also showed complementary effects and increased While the initial development of recombinant OLV proteins was a biotechnologically intensive and time-consuming process (7, 8) , it represented a one-time investment of resources and effort. After that, it was possible to produce and purify sufficient recombinant antigen in 2 days to test several thousand sheep serum specimens. Moreover, the growth and technical requirements for bacterial culture of Escherichia coli to produce recombinant proteins are simpler and less expensive than those for tissue culture of lentiviruses to produce conventional antigens. Thus, given the inherently faster and simpler in vitro culture of bacteria than that of viruses, recombinant proteins offer the potential for reduced cost per animal tested. Similarly, identification of diagnostically relevant synthetic peptide epitopes was a one-time resource investment. However, peptide synthesis is much more expensive than recombinant protein production. Furthermore, recombinant proteins appear to be more sensitive for OLV serodiagnosis than either viral lysates or synthetic peptides. Also, the signalto-noise ratio tended to be higher for the recombinant transmembrane ELISA than for the synthetic peptide assay among samples that were positive by both assays, facilitating discrimination between negative and positive animals by the secondgeneration antigen.
Thus, our overall conclusion is that OLV second-generation recombinant proteins offer the best combination of economy and test performance compared with their first-or thirdgeneration counterparts.
